Business news – Page 100
-
Business
US approves new anaemia drug
US authorities have approved Omontys (peginesatide) injections for treating anaemia in dialysis patients with chronic kidney disease
-
Business
Business roundup: April 2012
Pharmaceutical A pill to keep you off the pints? Source: © IStockphoto Beer today, gone tomorrow - Selincro tablets might help patients put their alcohol problems behind them Phase III trials of Selincro (nalmefene) tablets show that it outperforms placebo treatment when used to help patients with ...
-
Business
Light materials from Bayer
Bayer has launched a lightweight material designed to replace steel in railway locomotive and carriage construction
-
Business
PCSK9 inhibitors against cholesterol problems perform well
Sanofi has reported Phase II data for a new drug candidate for lowering cholesterol levels in patients already taking statins
-
Business
$500m for Ista
US eye drug company Bausch & Lomb has signed a cash deal to buy US drugmaker Ista Pharmaceuticals for $9.10 per share, equivalent to $500 million
-
Business
Court throws out patent covering drug dosing
The US Supreme Court has said that medical tests that rely on correlations between drug doses and treatment cannot be patented
-
Business
EPA proposes new rules for five chemicals
The US Environmental Protection Agency has proposed new rules that would force companies to report any new use
-
Business
AbbVie emerges from Abbott split
US healthcare giant Abbott has renamed the branded drugs part of its business
-
Business
GSK to build £350m factory in UK
GlaxoSmithKline (GSK) has announced £350 million plans to build its first new UK production plant for almost 40 years in Ulverston, Cumbria
-
News
GSK to build £350 million factory in UK
Tax breaks in the UK budget have prompted GSK to reaffirm its commitment
-
News
India green lights production of patented cancer drug
For the first time India has invoked a ‘compulsory licence’ clause to cut the cost of a patented anti-cancer drug
-
FeatureRising from the ashes
Neil Sinclair reports on some exciting new ventures emerging from redundant chemical and pharmaceutical plants
-
OpinionThe elements of drug design
Drug discovery requires experimentation, says Derek Lowe. But chemists can be reluctant to stray from the elements they know and love
-
Business
Business roundup: March 2012
Pharmaceutical Collaboration for neglected tropical diseases A group of 13 pharma companies, three national governments and several global health organisations has come together to target 10 neglected tropical diseases (NTDs) with $785 million (?497 million) in R&D funding. The group aims to ’accelerate progress toward eliminating or controlling [this set ...
-
Opinion
The language of the lab
Derek Lowe wonders what the lab lingua franca might be in the years to come
-
Business
Business roundup: February 2012
Pharmaceutical BMS spends $2.5 billion on antiviral firm Pharma giant Bristol-Myers Squibb (BMS) has struck a deal to buy US biotech Inhibitex for $2.5 billion (?1.6 billion). The move will stock BMS’s pipeline with antivirals, most notably INX-189, a nucleotide polymerase inhibitor which is in Phase II trials for treating ...
-
Opinion
Rewards of repurposing
Derek Lowe discusses how companies are increasingly trying to do more with the compounds they already know a lot about
-
Business
Business roundup: January 2012
Pharmaceutical Mental health drug use up More than one fifth of adults in the US took a mental health drug of some kind in 2010, according to a new report. The authors from Medco Health Solutions, a US pharmacy services company, found that use was higher for women than for ...
-
-
Business
Business roundup: December 2011
Almac to hire 500 over next 12 months UK contract research organisation (CRO) Almac says that it expects to hire about 500 people in the next 12 months, split between its headquarters in Craigavon, Northern Ireland, and its new US site in Souderton, Pennsylvania. Almac, a privately owned company, is ...